Showing results (841-850 of 1,402) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|May 24, 2023
Impact of a computerized physician order entry system on medication safety in pediatrics-The AVOID studyStefan Wimmer, Irmgard Toni, Sebastian Botzenhardt, et al.Pharmacology Research & Perspectives|April 21, 2023
Information overdose: Student performance and perceptions of pharmacology resources on examsMarieke Kruidering-Hall, Rupa Lalchandani TuanPharmacology Research & Perspectives|June 26, 2019
Inhibiting the immunoproteasome's β5i catalytic activity affects human peripheral blood-derived immune cell viabilityKatrien Pletinckx, Silke Vaßen, Ilka Schlusche, et al.Pharmacology Research & Perspectives|August 29, 2018
Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal ModelsCatherine M Sampson, James M Kasper, Daniel E Felsing, et al.Pharmacology Research & Perspectives|May 4, 2019
The effect of chronic kidney disease on CYP2B expression and activity in male Wistar ratsAndrew S Kucey, Thomas J Velenosi, Nicholas C Tonial, et al.Pharmacology Research & Perspectives|August 4, 2018
Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in EritreaMulugeta Russom, Merhawi Debesai, Mehari Zeregabr, et al.Pharmacology Research & Perspectives|May 9, 2017
FTY720 elevates smooth muscle contraction of aorta and blood pressure in rats via ERK activationZhen Zhao, Jinxin Wang, Zhijun Huo, et al.Pharmacology Research & Perspectives|May 9, 2018
Effects of magnesium chloride on in vitro cholinesterase and ATPase poisoning by organophosphate (chlorpyrifos)Bamidele S Ajilore, Adetayo A Alli, Tolulope O OluwadairoPharmacology Research & Perspectives|June 1, 2019
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomesDaniela Mercatelli, Paolo Bolognesi, Martina Frassineti, et al.Pharmacology Research & Perspectives|June 1, 2019
l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathwayOlivia J Robertson-Gray, Sarah K Walsh, Erik Ryberg, et al.Pageof 141